TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$13.13
arrow_downward
-1.80%(-0.24) 1D
Sep 4, 1:52:53 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
$13.30
High
$13.33
Low
$12.99
Mkt. cap
225.19M
Avg. vol.
482.32K
Volume
139.77K
52-wk high
$31.55
52-wk low
$9.40
EPS
-$12.92
Beta
1.74
Shares outstanding
17.15M
No. of employees
142
Open
$13.30
High
$13.33
Low
$12.99
Mkt. cap
225.19M
Avg. vol.
482.32K
Volume
139.77K
52-wk high
$31.55
52-wk low
$9.40
EPS
-$12.92
Beta
1.74
Shares outstanding
17.15M
No. of employees
142
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitetonixpharma.com